Huntington’s disease (HD) is a progressive, neurodegenerative disorder that affects movement, cognition, and mood. It is caused by a mutated gene that leads to the production of an abnormal form of the huntingtin protein. This disruption results in the gradual degeneration of brain cells, particularly in the striatum and cerebral cortex. Diagnosing HD is crucial for early intervention and management of symptoms. This article discusses three ways to diagnose Huntington’s disease.

1. Clinical assessment:

A comprehensive clinical evaluation is conducted by a neurologist or movement disorder specialist to determine if a patient exhibits signs and symptoms consistent with HD. This assessment includes evaluating the patient’s medical and family history, as well as conducting a physical examination to observe any motor abnormalities, such as chorea (involuntary movements), gait disturbances, rigidity, or dystonia (muscle contractions). A neurological examination is also performed to assess cognitive abilities, memory function, language skills, and emotional state. While these assessments cannot definitively diagnose HD on their own, they provide valuable information about symptom presentation and severity.

2. Genetic testing:

HD is an autosomal dominant genetic disorder, which means that a person only needs to inherit one copy of the mutated gene from an affected parent to develop the illness. Genetic testing can confirm whether an individual has inherited the mutated HTT gene responsible for HD by analyzing their DNA. This process involves collecting a blood sample from the patient and analyzing it in a laboratory to identify any abnormal repetitions in the HTT gene’s coding region.

Genetic testing can be performed as either predictive testing or diagnostic testing. Predictive testing is done before symptoms manifest when a person has a family history of HD but does not yet have symptoms themselves. Diagnostic testing occurs once a person starts exhibiting symptoms consistent with HD and helps confirm the diagnosis.

3. Brain imaging:

Advanced imaging techniques, such as magnetic resonance imaging (MRI) or computed tomography (CT) scans, can provide insight into the structural changes occurring within the brain of a person with HD. These technologies can detect atrophy (shrinkage) in specific areas of the brain affected by HD, such as the striatum and cerebral cortex. While brain imaging alone cannot definitively diagnose HD, it serves as a useful tool in combination with clinical assessments and genetic testing to provide a comprehensive understanding of the patient’s condition.

In conclusion, diagnosing Huntington’s disease relies on a combination of clinical assessment, genetic testing, and brain imaging. Early diagnosis is essential for managing symptoms, anticipating potential complications, and tailoring treatment plans to improve the affected individual’s quality of life. If you suspect that you or a loved one may be at risk for HD or are experiencing symptoms associated with the disease, consult with a healthcare professional specializing in neurology or movement disorders for further evaluation.